Intraperitoneal Infusion Improves CAR-T Cell Therapy in Solid Tumor Models
In solid tumor models, intraperitoneal infusion improved CAR-T cell antitumor efficacy and persistence compared to standard intravenous delivery.
In solid tumor models, intraperitoneal infusion improved CAR-T cell antitumor efficacy and persistence compared to standard intravenous delivery.
A spatial analysis of 13,112 platform-reported pediatric major-disease cases in mainland China reveals pronounced regional clustering, healthcare resource inequalities, and ...
A prospective emergency department cohort study found that MASCC and CISNE scores had comparable discrimination for 30- and 90-day mortality ...
A scientific review highlights Musashi-2 as a context-dependent post-transcriptional organizer involved in stabilizing pathological cellular states across diverse diseases.
Engineered CAR-T cells equipped with a synthetic radiation-inducible promoter locally release tumor necrosis factor upon tumor irradiation to enhance antitumor ...
A scientific review published in Cancer Cell International highlights ATG5 as a context-dependent molecular switch driving therapy resistance and survival ...
Researchers report that the epigenetic regulator BAZ2A drives renal cancer cells to accumulate palmitic acid, which impairs CAR-T cell mitochondria ...
Engineered IL-6-responsive CAR macrophages enhanced CAR-T cell antitumor activity, matrix remodeling, and survival in preclinical solid tumor models.
A new review synthesizes engineering strategies and early clinical findings for CAR-NK cell immunotherapy in blood cancers and solid tumors.
A prospective metabolomic study of 35 patients with solid tumors found that ascites fluid shows distinct metabolic profiles depending on ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine